Interstitial Lung Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with early-stage IPF (idiopathic pulmonary fibrosis — a lung scarring condition) based on both clinical assessment and imaging results such as a CT scan.
Who may not be able to join:
- People who have a strong medical reason why they cannot safely undergo a bronchoalveolar lavage (a procedure where a small amount of fluid is flushed into the lungs and collected for testing) or an MRI scan.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Assessment of the ability of advanced magnetic resonance imaging techniques to assess tissue oxygenation and local hypoxia in early interstitial pulmonary fibrosis (proliferative stage)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.